Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
A live audio webcast of the company鈥檚 presentation will be available by visiting Veracyte鈥檚 website at . A replay of the webcast will be available for 90 days after the live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit or follow us on or .
View source version on businesswire.com:
Investors:
Shayla Gorman
[email protected]
(619) 393-1545
Media:
Tracy Morris
[email protected]
(650) 380-4413
Source: Veracyte, Inc.
